Sunshine Biopharma launches generic doxycycline in Canada
PositiveFinancial Markets

Sunshine Biopharma has successfully launched its generic version of doxycycline in Canada, marking a significant milestone for the company. This launch is important as doxycycline is widely used to treat various infections and conditions, making it a valuable addition to the Canadian pharmaceutical market. By providing a generic option, Sunshine Biopharma aims to enhance accessibility and affordability for patients, which is crucial in today's healthcare landscape.
— Curated by the World Pulse Now AI Editorial System